RISE - emcure.com

1 Resilience Innovation Scale ExecutionAnnual Report 2021 RISEEMCURE AT A GLANCEE mcure s name embodies the company s purpose and core belief to make effective medicine accessible to patients, enabling them to lead healthier lives. Since its inception in 1981, Emcure has established a vertically integrated infrastructure for developing and manufacturing a wide range of medicines and marketing them in India and abroad. Emcure is, today, ranked amongst the leading pharmaceutical players in , one of Emcure s core values, is ingrained in our culture and reflected in all our operations. Our Business Strategy, driven by the entrepreneurial spirit, has led us to adopt different business models across geographies. Emcure s operations are focused towards building a robust product portfolio including differentiated platforms such as Novel Drug Delivery Systems, Biologics, Chiral chemistry, Injectables etc. Emcure aims at creating strong brand equity by promoting top class products. We are oriented towards serving our customers, consumers and community globally and thus we have the highest regard for quality.

Emcure’s name embodies the company’s purpose and core belief – to make effective medicine accessible to patients, ... In a fast changing global pharmaceutical industry, it has been our constant ... 1000 1500 2000 2500 3000 3500 4000 4500 5000 5072 0% 5% 10% 15% 20% 25% 22% 0 10000 20000 30000 40000 50000 60000 70000 FY17 FY18 FY19 FY20 FY21

Loading..

Tags:

  Company, Pharmaceutical, Global, 1000, Global pharmaceutical

Information

Related search queries